Physical mapping of human insulin-like growth factor-I using specific monoclonal antibodies

Journal of Endocrinology

Volumn 154, Issue 2, 1997, Pages 293-302

  Manes S ^a   Kremer, L ^a   Vangbo, B ^b   Lopez A ^a   Gomez Mouton C ^a   Peiro E ^a   Albar, J P ^a   Mendel Hartvig, I B ^b   Llopis, R ^a,c   Martinez A C ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Peptide Hormones   (Sweden)

^c Fundación Club de Inversores   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; SOMATOMEDIN;

AMINO ACID SEQUENCE; ARTICLE; CANCER CONTROL; CARBOXY TERMINAL SEQUENCE; HORMONE DETERMINATION; HORMONE STRUCTURE; PEPTIDE MAPPING; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

EID: 0040776936     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1540293     Document Type: Article

References (35)

1. Atherton E & Sheppard RC 1989 Solid Phase Synthesis: a Practical Approach. Oxford: IRL Press.
2. Axelsson K, Johansson S, Eketorp G, Zazzi H, Hemmendorf B & Gellerfors P 1992 Disulfide arrangement of human insulin-like growth factor-I derived from yeast and plasma. European Journal of Biochemistry 206 987-994.
3. Bala RM & Bhaumick B 1977 Radioimmunoassay of a basic somatomedin: comparison of various assay techniques and somatomedin levels in various sera. Journal of Clinical Endocrinology and Metabolism 49 770-775.
4. Baserga R 1994 Oncogenes and the strategy of growth factors. Cell 79 927-930.
5. Baxter RC, Axiak S & Raison RL 1982 Monoclonal antibodies against human somatomedin-C/insulin-like growth factor-I. Journal of Clinical Endocrinology and Metabolism 54 474-476.
6. Cascieri MA, Bayne ML, Ber E, Green BG, Men GW & Chicchi GG 1990 Identification of the insulin-like growth factor-I (IGF-I) epitopes recognized by monoclonal and polyclonal antibodies to IGF-I. Endocrinology 126 2773-2777.
7. Cooke RM, Harvey TS & Campbell ID 1991 Solution structure of human insulin-like growth factor-I: a nuclear magnetic resonance and restrained molecular dynamics study. Biochemistry 30 5484-5491.
8. Davies DR, Padlan EA & Sheriff S 1990 Antibody-antigen complexes. Annual Review of Biochemistry 59 439-473.
9. Francis GL, Ross M, Ballard FJ, Milner SJ, Senn C, McNeil KA, Wallace JC, King R & Wells JRE 1992 Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF binding protein and receptor binding for enhanced biological potency. Journal of Molecular Endocrinology 8 213-223.
10. Furlanetto RW, Underwood LE, Van Wyk JJ & D'Ercole AJ 1977 Estimation of somatomedin C levels in normals and patients with pituitary disease by radioimmunoassay. Journal of Clinical Investigation 60 648-652.
11. Gellerfors P, Axelsson K, Helander A, Johansson S, Kenne L, Lindqvist S, Pavlu B, Skottner A & Fryklund L 1989 Isolation and characterization of a glycosylated form of insulin-like growth factor-I produced in Saccharomyces cerevisiae. Journal of Biological Chemistry 264 11444-11449.
12. Gillespie GY, Van Wyk JJ, Underwood LE & Svoboda ME 1987 Derivation of monoclonal antibodies to human somatomedin C/insulin-like growth factor-I. Methods in Enzymology 146 207-216.
13. Glick RP, Unterman TG & Hollis R 1991 Radioimmunoassay of insulin-like growth factors in cyst fluid of central nervous system tumors. Journal of Neurosurgery 74 972-978.
14. Harvey D, Jones WT, Jones SD & Ryan GB 1993 Production of monoclonal, antibodies recognising different epitopes present on insulin-like growth factor-I. Hybridoma 12 737-744.
15. Hejnaes KR, Bayne S, Nörskov L, Sörensen HH, Thomsen J, Schöffer L, Wollmer A & Skriver L 1992 Development of an optimized refolding process for recombinant Ala-Glu-IGF-1. Protein Engineering 5 797-806.
16. Hintz RL, Liu F, Marshall LB & Chang D 1980a Interaction of somatomedin C with an antibody directed against the synthetic C-peptide region of insulin-like growth factor-I. Journal of Clinical Endocrinology and Metabolism 50 405-407.
17. Hintz RL, Liu F & Riderknecht E 1980b Somatomedin C shares the carboxy-terminal antigenic determinants with insulin-like growth factor-I. Journal of Clinical Endocrinology and Metabolism 51 672-673.
18. Hodges RS, Heaton RJ & Parker JM 1988 Antigen-antibody interaction. Synthetic peptides define linear antigenic determinants recognized by monoclonal antibodies directed to the cytoplasmic carboxyl terminus of rhodopsin. Journal of Biological Chemistry 263 11768-11775.
19. Jones JI & Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 16 3-34.
20. 3, following their expression in Escherichia coli as fusion proteins. Journal of Molecular Endocrinology 8 29-41.
21. Laubli UK, Baier W, Binz H, Celio MR & Humbel RE 1982 Monoclonal antibodies directed to human insulin-like growth factor-I (IGF-I): use for radioimmunoassay and immunopuritication of IGF-I. FEBS Letters 149 109-112.
22. Mañes S, Kremer L, Albar JP, Mark C, Llopis R & Martinez-A C 1997 Functional epitope mapping of insulin-like growth factor-I by anti-IGF-I monoclonal antibodies. Endocrinology 138 905-915.
23. Morrell DJ, Dadi H, More J, Taylor AM, Dabestani A, Buchanan CR, Holder AT & Preece MA 1989 A monoclonal antibody to human insulin-like growth factor-I: characterization, use in radioimmunoassay and effect on biological activities of the growth factor. Journal of Molecular Endocrinology 2 201-206.
24. Porcu P, Ferber A, Pietrzkowski Z, Roberts CT, Adamo M, LeRoith D & Baserga R 1992 The growth stimulatory effect of simian virus 40 T antigen requires the interaction of insulin-like growth factor-I with its receptor. Molecular and Cellular Biology 12 5069-5077.
25. Rinderknecht E & Humbel RE 1976 Polypeptides with nonsuppressible insulin-like and cell growth promoting activity in human serum: isolation, chemical characterization and some biological properties. Proceedings of the National Academy of Sciences of the USA 73 2365-2369.
26. Rinderknecht E & Humbel RE 1978 The amino acid sequence of human insulin-like growth factor-I and its structural homology with proinsulin. Journal of Biological Chemistry 253 2769-2776.
27. Sara VR & Hall K 1990 Insulin-like growth factors and their binding proteins. Physiological Reviews 70 591-614.
28. Scott MG, Cuca GC, Petersen JR, Lyle LR, Burleigh BD & Daughaday WH 1987 Specific immunoradiometric assay of insulin-like growth factor-I with use of monoclonal antibodies. Clinical Chemistry 33 2019-2023.
29. Sell C, Rubini M, Rubin R, Liu J-P, Efstratiadis A & Baserga R 1993 Simian virus 40 large tumor antigen is unable to transform fibroblasts lacking Type-1 insulin-like growth factor receptor. Proceedings of the National Academy of Sciences of the USA 90 11217-11221.
30. Tam JP 1988 Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigen peptide system. Proceedings of the National Academy of Sciences of the USA 85 5409-5412.
31. Tamura E, Kobayashi M, Susuki S, Ishii Y, Koyama S, Yamada H, Hashimoto K, Niwa M & Shibayama F 1990 Enzyme-linked immunosorbent assay for human insulin-like growth factor-I using monoclonal and polyclonal antibodies with defined epitope recognition. Journal of Endocrinology 125 327-335.
32. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, Jacobs S, Francke U, Ramachandran J & Fujita-Yamaguchi Y 1986 Insulin-like growth factor-I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO Journal 5 2503-2512.
33. VanCott TC, Loomis LD, Redfield RR & Birx DL 1992 Real-time biospecific interaction analysis of antibody reactivity to peptides from the envelope glycoprotein, gp160, of HIV-1. Journal of Immunological Methods 146 163-176.
34. Werner H, Shen-Orr Z, Rauscher III FJ, Moms JF, Roberts CT & LeRoith D 1995 Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor-I receptor gene expression. Molecular and Cellular Biology 15 3516-3522.
35. Zapf J, Rinderknecht E, Humbel RE & Froesch ER 1978 Nonsuppressible insulin-like activity (NSILA) from human serum: recent accomplishments and their physiological implication. Journal of Endocrinology 125 1803-1810.